Organon & Co. Stock News

Whittier Trust Co. reduced its stake in Organon & Co. (NYSE:OGN) by 19.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,763 shares of the company’s stock after selling 3,753 shares during the period. Whittier Trust Co.’s holdings in Organon & Co. were […] The post Whittier Trust Co. Sells 3,753 Shares of Organon & Co. (NYSE:OGN) appeared first on ETF Daily News .

State of New Jersey Common Pension Fund D lowered its position in shares of Organon & Co. (NYSE:OGN) by 0.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 148,930 shares of the companys stock after selling 1,055 shares during the quarter. State of New []

Related Stocks: DCI , ARNC , SYNH , PXD , OGN , AA , EXC , ZBH , ETR , AN , HUN , DAL , TROX ,

Organon & Co. (NYSE:OGN)s stock price gapped up before the market opened on Friday . The stock had previously closed at $29.33, but opened at $30.45. Organon & Co. shares last traded at $29.80, with a volume of 1,590 shares traded. Several equities analysts have weighed in on OGN shares. Zacks Investment Research upgraded Organon []

Calamos Advisors LLC raised its position in shares of Organon & Co. (NYSE:OGN) by 9.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 55,582 shares of the companys stock after purchasing an additional 4,904 shares during the quarter. Calamos Advisors LLCs holdings []

Beddow Capital Management Inc. lifted its position in Organon & Co. (NYSE:OGN) by 70.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,645 shares of the company’s stock after acquiring an additional 39,662 shares during the quarter. Organon & Co. […]

Carret Asset Management LLC lifted its position in Organon & Co. (NYSE:OGN) by 5.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 91,567 shares of the company’s stock after purchasing an additional 5,099 shares during the quarter. Carret Asset Management LLC’s holdings […]

STOCKHOLM SWEDEN - December 13, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the previously announced transaction, in which the global pharmaceutical company Organo…

STOCKHOLM SWEDEN December 13, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the previously announced transaction, in which the global pharmaceutical company Organon & Co. (NYSE:OGN) acquires Karolinska Development''s portfolio company Forendo Pharma, has now been completed. This is one of the largest commercial deals in the Nordic biotech sector in 2021.

Expands women''s health pipeline with novel candidates targeting endometriosis and polycystic ovarian syndrome (PCOS) Organon (NYSE: OGN), a global women''s healthcare company, today announced the c…

JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Endometriosis--Organon Announces Close of Forendo Pharma

Virginia Retirement Systems ET AL cut its position in shares of Organon & Co. (NYSE:OGN) by 50.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,900 shares of the company’s stock after selling 25,519 shares during the period. Virginia Retirement Systems […]

Organon fell after posting quarterly results.

Balasa Dinverno & Foltz LLC purchased a new stake in shares of Organon & Co. (NYSE:OGN) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 27,845 shares of the companys stock, valued at approximately $913,000. A number of other large investors have []